New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Alpine Immune Sciences, Inc.
ALPN
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

4B

Biotechnology

Next Earning date - 12 Nov 2024

4B

Biotechnology

Next Earning date - 12 Nov 2024

64.97USD
Shape0.01 ( 0.02%)
favorite-chart

Relative Strenght

99
favorite-chart

Volume Buzz

81%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

0%

Quote Panel

Shape
Updated October 26, 2024
1W % 1M % 3M % 1Y 598.60 %

Key Metrics

Shape
  • Market Cap

    4.46B


  • Shares Outstanding

    68.60M


  • Share in Float

    47.88M


  • Dividende

    0


  • Earning Date

    12 Nov 2024


  • Price Target

    64.97


  • Average Volume

    2.37M


  • Beta

    0.969


  • Range

    8.33-65.0


  • Industry

    Biotechnology


  • Website

    https://www.alpineimmunesciences.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

78.85x

P/S Ratio

12.50x

P/B Ratio

0.0

Debt/Equity

-65.2%

Net Margin

$-0.6

EPS

How ALPN compares to sector?

P/E Ratio

Relative Strength

Shape

ALPN

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$20M

Shape187%

2025-Revenue

$1.76

Shape-527%

2025-EPS

$19M

Shape15%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Cowen & Co.

downgrade

Previous: Not converted

2024-04-15

Now: Hold

Leerink Partners

downgrade

Previous: Not converted

2024-04-12

Now: Market Perform

Guggenheim

initialise

Previous: Not converted

2024-04-09

Now: Buy

RBC Capital

initialise

Previous: Not converted

2023-10-05

Now: Outperform

Earnings GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

N/A

-0.60
vs -0.46

Q3.22

arrow
arrow

N/A

-0.42
vs -0.55

Q4.22

arrow
arrow

N/A

-0.41
vs -0.52

Q1.23

arrow
arrow

N/A

-0.28
vs -0.25

Q2.23

arrow
arrow

N/A

-0.27
vs -0.60

Q3.23

arrow
arrow

N/A

-0.24
vs -0.42

Q4.23

arrow
arrow

+137%

0.15
vs -0.41

Q1.24

arrow
arrow

N/A

-0.28
vs -0.28

Q3.24

arrow
arrow

N/A

-0.41
vs -0.24

Q4.24

arrow
arrow

N/A

-0.44
vs 0.15

Sales GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

-26%

5.3M  vs 7.2M

Q3.22

arrow
arrow

-2%

8.4M  vs 8.5M

Q4.22

arrow
arrow

-39%

2.8M  vs 4.5M

Q1.23

arrow
arrow

-31%

9.4M  vs 13.6M

Q2.23

arrow
arrow

+62%

8.6M  vs 5.3M

Q3.23

arrow
arrow

+20%

10M  vs 8.4M

Q4.23

arrow
arrow

+1011%

30.9M  vs 2.8M

Q1.24

arrow
arrow

-25%

7M  vs 9.4M

Q3.24

arrow
arrow

-70%

3M  vs 10M

Q4.24

arrow
arrow

-90%

3M  vs 30.9M

Return on EquityShape

status-upQoQ

Q2.22

arrow
arrow

-18%

-0.18
vs -0.07

Q3.22

arrow
arrow

-7%

-0.07
vs -0.18

Q4.22

arrow
arrow

-11%

-0.11
vs -0.07

Q1.23

arrow
arrow

-6%

-0.06
vs -0.11

Q2.23

arrow
arrow

-8%

-0.08
vs -0.06

Q3.23

arrow
arrow

-7%

-0.07
vs -0.08

Q4.23

arrow
arrow

+2%

0.02
vs -0.07

Q1.24

arrow
arrow

-5%

-0.05
vs 0.02

Institutionnal OwnershipShape

status-upQoQ

Q2.22

arrow
arrow

57

57
vs 56

2%

Q3.22

arrow
arrow

67

67
vs 57

18%

Q4.22

arrow
arrow

64

64
vs 67

-4%

Q1.23

arrow
arrow

59

59
vs 64

-8%

Q2.23

arrow
arrow

77

77
vs 59

31%

Q3.23

arrow
arrow

89

89
vs 77

16%

Q4.23

arrow
arrow

135

135
vs 89

52%

Q1.24

arrow
arrow

190

190
vs 135

41%

Earnings Growth

Latest News